verathon medical (uk) ltd Company Information
Company Number
03867024
Next Accounts
Sep 2025
Industry
Agents specialised in the sale of other particular products
Shareholders
verathon medical inc
Group Structure
View All
Contact
Registered Address
rutland house 148 edmund street, birmingham, B3 2JR
Website
www.verathon.co.ukverathon medical (uk) ltd Estimated Valuation
Pomanda estimates the enterprise value of VERATHON MEDICAL (UK) LTD at £7.1m based on a Turnover of £15m and 0.47x industry multiple (adjusted for size and gross margin).
verathon medical (uk) ltd Estimated Valuation
Pomanda estimates the enterprise value of VERATHON MEDICAL (UK) LTD at £7.1m based on an EBITDA of £1.3m and a 5.44x industry multiple (adjusted for size and gross margin).
verathon medical (uk) ltd Estimated Valuation
Pomanda estimates the enterprise value of VERATHON MEDICAL (UK) LTD at £7.7m based on Net Assets of £5.9m and 1.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Verathon Medical (uk) Ltd Overview
Verathon Medical (uk) Ltd is a live company located in birmingham, B3 2JR with a Companies House number of 03867024. It operates in the agents specialized in the sale of other particular products sector, SIC Code 46180. Founded in October 1999, it's largest shareholder is verathon medical inc with a 100% stake. Verathon Medical (uk) Ltd is a mature, mid sized company, Pomanda has estimated its turnover at £15m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Verathon Medical (uk) Ltd Health Check
Pomanda's financial health check has awarded Verathon Medical (Uk) Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
3 Regular
3 Weak
Size
annual sales of £15m, make it larger than the average company (£9.4m)
£15m - Verathon Medical (uk) Ltd
£9.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (7.4%)
-12% - Verathon Medical (uk) Ltd
7.4% - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (29.3%)
32.4% - Verathon Medical (uk) Ltd
29.3% - Industry AVG
Profitability
an operating margin of 8.6% make it more profitable than the average company (5.9%)
8.6% - Verathon Medical (uk) Ltd
5.9% - Industry AVG
Employees
with 20 employees, this is above the industry average (15)
20 - Verathon Medical (uk) Ltd
15 - Industry AVG
Pay Structure
on an average salary of £123.3k, the company has a higher pay structure (£60.5k)
£123.3k - Verathon Medical (uk) Ltd
£60.5k - Industry AVG
Efficiency
resulting in sales per employee of £751.3k, this is more efficient (£424.5k)
£751.3k - Verathon Medical (uk) Ltd
£424.5k - Industry AVG
Debtor Days
it gets paid by customers after 52 days, this is near the average (51 days)
52 days - Verathon Medical (uk) Ltd
51 days - Industry AVG
Creditor Days
its suppliers are paid after 3 days, this is quicker than average (26 days)
3 days - Verathon Medical (uk) Ltd
26 days - Industry AVG
Stock Days
it holds stock equivalent to 1 days, this is less than average (69 days)
1 days - Verathon Medical (uk) Ltd
69 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 66 weeks, this is more cash available to meet short term requirements (17 weeks)
66 weeks - Verathon Medical (uk) Ltd
17 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 59%, this is a similar level of debt than the average (54%)
59% - Verathon Medical (uk) Ltd
54% - Industry AVG
VERATHON MEDICAL (UK) LTD financials
Verathon Medical (Uk) Ltd's latest turnover from December 2023 is £15 million and the company has net assets of £5.9 million. According to their latest financial statements, Verathon Medical (Uk) Ltd has 20 employees and maintains cash reserves of £6.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 15,025,016 | 10,663,410 | 11,945,798 | 22,098,990 | 9,430,241 | 7,822,998 | 6,636,742 | 5,296,488 | 4,917,146 | 5,609,677 | 5,050,591 | 4,667,310 | 3,631,123 | 3,743,192 | 4,196,441 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost Of Sales | 10,157,424 | 6,928,178 | 8,273,104 | 17,157,130 | 5,870,932 | 4,662,806 | 3,679,592 | 3,146,041 | 2,325,733 | 2,176,144 | 2,612,674 | 2,104,863 | 1,553,074 | 1,608,268 | 1,874,712 |
Gross Profit | 4,867,592 | 3,735,232 | 3,672,694 | 4,941,860 | 3,559,309 | 3,160,192 | 2,957,150 | 2,150,447 | 2,591,413 | 3,433,533 | 2,437,917 | 2,562,447 | 2,078,049 | 2,134,924 | 2,321,729 |
Admin Expenses | 3,570,462 | 2,339,136 | 2,507,234 | 3,501,966 | 2,804,144 | 2,698,047 | 2,611,100 | 1,894,786 | 2,116,601 | 2,727,588 | 2,798,358 | 2,497,211 | 2,366,517 | 1,860,140 | 2,183,128 |
Operating Profit | 1,297,130 | 1,396,096 | 1,165,460 | 1,439,894 | 755,165 | 462,145 | 346,050 | 255,661 | 474,812 | 705,945 | -360,441 | 65,236 | -288,468 | 274,784 | 138,601 |
Interest Payable | 0 | 6,797 | 45,740 | 45,600 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Receivable | 231,545 | 134,822 | 39,447 | 152,885 | 143,651 | 134,792 | 74,159 | 313 | 28 | 23 | 674 | 626 | 348 | 299 | 406 |
Pre-Tax Profit | 1,528,675 | 1,524,121 | 1,159,167 | 1,547,179 | 898,816 | 596,937 | 420,209 | 255,974 | 474,840 | 705,968 | -359,767 | 65,862 | -288,120 | 275,083 | 139,007 |
Tax | 97,388 | 16,341 | 277,581 | -563,287 | -169,737 | 24,244 | -24,244 | 39,097 | -99,127 | -157 | 0 | -153 | 34,202 | -34,316 | 0 |
Profit After Tax | 1,626,063 | 1,540,462 | 1,436,748 | 983,892 | 729,079 | 621,181 | 395,965 | 295,071 | 375,713 | 705,811 | -359,767 | 65,709 | -253,918 | 240,767 | 139,007 |
Dividends Paid | 0 | 0 | 2,541,982 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | 1,626,063 | 1,540,462 | -1,105,234 | 983,892 | 729,079 | 621,181 | 395,965 | 295,071 | 375,713 | 705,811 | -359,767 | 65,709 | -253,918 | 240,767 | 139,007 |
Employee Costs | 2,466,490 | 1,673,393 | 1,668,907 | 2,748,876 | 1,996,951 | 1,749,386 | 1,714,799 | 1,026,786 | 1,272,556 | 1,656,985 | 1,647,414 | 1,667,377 | 1,412,330 | 1,166,550 | 1,371,785 |
Number Of Employees | 20 | 17 | 15 | 13 | 16 | 15 | 12 | 11 | 22 | 20 | 19 | 21 | 24 | 22 | 23 |
EBITDA* | 1,297,130 | 1,396,096 | 1,165,460 | 1,439,894 | 755,165 | 462,145 | 346,986 | 266,096 | 506,685 | 741,265 | -312,611 | 113,010 | -238,673 | 313,509 | 170,726 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,203 | 30,699 | 56,395 | 100,396 | 144,117 | 165,585 | 188,970 | 69,224 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 5,200,000 | 5,200,000 | 5,200,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 5,200,000 | 5,200,000 | 5,200,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,203 | 30,699 | 56,395 | 100,396 | 144,117 | 165,585 | 188,970 | 69,224 |
Stock & work in progress | 36,967 | 107,703 | 17,640 | 19,164 | 145,034 | 678,990 | 579,772 | 0 | 544,236 | 323,571 | 493,956 | 575,408 | 696,556 | 928,564 | 971,308 |
Trade Debtors | 2,172,790 | 2,123,910 | 2,029,816 | 7,589,979 | 2,759,294 | 1,903,195 | 1,191,474 | 685,313 | 475,853 | 980,554 | 1,422,436 | 475,280 | 516,984 | 694,567 | 509,079 |
Group Debtors | 276,543 | 137,244 | 2,422 | 504,957 | 352,072 | 208,518 | 75,650 | 0 | 0 | 411,839 | 0 | 0 | 0 | 1,199 | 0 |
Misc Debtors | 11,977 | 475,897 | 429,990 | 5,080 | 2,577 | 24,554 | 58,995 | 103,297 | 39,415 | 44,873 | 54,287 | 62,449 | 145,993 | 56,012 | 37,911 |
Cash | 6,781,796 | 2,851,072 | 2,186,948 | 4,001,253 | 1,814,192 | 1,218,578 | 790,558 | 2,620,188 | 1,260,551 | 299,745 | 165,225 | 645,538 | 293,726 | 400,275 | 663,564 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,002 |
total current assets | 9,280,073 | 5,695,826 | 4,666,816 | 12,120,433 | 5,073,169 | 4,033,835 | 2,696,449 | 3,408,798 | 2,320,055 | 2,060,582 | 2,135,904 | 1,758,675 | 1,653,259 | 2,080,617 | 2,182,864 |
total assets | 14,480,073 | 10,895,826 | 9,866,816 | 14,120,433 | 7,073,169 | 6,033,835 | 4,696,449 | 3,410,001 | 2,350,754 | 2,116,977 | 2,236,300 | 1,902,792 | 1,818,844 | 2,269,587 | 2,252,088 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 106,531 | 20,039 | 350,277 | 316,454 | 82,596 | 71,452 | 27,375 | 48,361 | 63,431 | 70,829 | 80,334 | 106,285 | 41,324 | 87,321 | 36,335 |
Group/Directors Accounts | 4,003,065 | 3,046,717 | 3,372,689 | 5,594,670 | 1,507,421 | 1,731,298 | 1,149,297 | 942,817 | 167,920 | 0 | 191,001 | 262,484 | 216,495 | 257,067 | 332,832 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 1,210,191 | 791,098 | 1,830,340 | 3,616,798 | 1,886,948 | 1,588,198 | 1,684,828 | 1,039,664 | 990,699 | 1,200,275 | 1,778,846 | 889,724 | 800,847 | 765,449 | 825,891 |
total current liabilities | 5,319,787 | 3,857,854 | 5,553,306 | 9,527,922 | 3,476,965 | 3,390,948 | 2,861,500 | 2,030,842 | 1,222,050 | 1,271,104 | 2,050,181 | 1,258,493 | 1,058,666 | 1,109,837 | 1,195,058 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 3,172,477 | 2,676,226 | 1,491,527 | 626,564 | 598,441 | 397,574 | 236,042 | 227,331 | 271,947 | 364,829 | 410,886 | 0 | 690,887 | 825,977 | 974,588 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 509,299 | 0 | 0 | 0 |
provisions | 44,573 | 44,573 | 45,272 | 84,002 | 99,710 | 76,339 | 51,114 | 0 | 0 | 0 | 0 | 0 | 0 | 10,564 | 0 |
total long term liabilities | 3,217,050 | 2,720,799 | 1,536,799 | 710,566 | 698,151 | 473,913 | 287,156 | 227,331 | 271,947 | 364,829 | 410,886 | 509,299 | 690,887 | 836,541 | 974,588 |
total liabilities | 8,536,837 | 6,578,653 | 7,090,105 | 10,238,488 | 4,175,116 | 3,864,861 | 3,148,656 | 2,258,173 | 1,493,997 | 1,635,933 | 2,461,067 | 1,767,792 | 1,749,553 | 1,946,378 | 2,169,646 |
net assets | 5,943,236 | 4,317,173 | 2,776,711 | 3,881,945 | 2,898,053 | 2,168,974 | 1,547,793 | 1,151,828 | 856,757 | 481,044 | -224,767 | 135,000 | 69,291 | 323,209 | 82,442 |
total shareholders funds | 5,943,236 | 4,317,173 | 2,776,711 | 3,881,945 | 2,898,053 | 2,168,974 | 1,547,793 | 1,151,828 | 856,757 | 481,044 | -224,767 | 135,000 | 69,291 | 323,209 | 82,442 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 1,297,130 | 1,396,096 | 1,165,460 | 1,439,894 | 755,165 | 462,145 | 346,050 | 255,661 | 474,812 | 705,945 | -360,441 | 65,236 | -288,468 | 274,784 | 138,601 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 936 | 10,435 | 31,873 | 35,320 | 47,830 | 47,774 | 49,795 | 38,725 | 32,125 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 97,388 | 16,341 | 277,581 | -563,287 | -169,737 | 24,244 | -24,244 | 39,097 | -99,127 | -157 | 0 | -153 | 34,202 | -34,316 | 0 |
Stock | -70,736 | 90,063 | -1,524 | -125,870 | -533,956 | 99,218 | 579,772 | -544,236 | 220,665 | -170,385 | -81,452 | -121,148 | -232,008 | -42,744 | 971,308 |
Debtors | -275,741 | 274,823 | -2,437,788 | 4,986,073 | 977,676 | 810,148 | 2,537,509 | 273,342 | -921,998 | -39,457 | 938,994 | -125,248 | -88,801 | 204,788 | 546,990 |
Creditors | 86,492 | -330,238 | 33,823 | 233,858 | 11,144 | 44,077 | -20,986 | -15,070 | -7,398 | -9,505 | -25,951 | 64,961 | -45,997 | 50,986 | 36,335 |
Accruals and Deferred Income | 915,344 | 145,457 | -921,495 | 1,757,973 | 499,617 | 64,902 | 653,875 | 4,349 | -302,458 | -624,628 | 1,300,008 | -602,010 | -99,692 | -209,053 | 1,800,479 |
Deferred Taxes & Provisions | 0 | -699 | -38,730 | -15,708 | 23,371 | 25,225 | 51,114 | 0 | 0 | 0 | 0 | 0 | -10,564 | 10,564 | 0 |
Cash flow from operations | 2,742,831 | 862,071 | 2,955,951 | -2,007,473 | 675,840 | -288,773 | -2,110,536 | 565,366 | 799,035 | 316,817 | 103,904 | -177,796 | -39,915 | -30,354 | 489,242 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 956,348 | -325,972 | -2,221,981 | 4,087,249 | -223,877 | 582,001 | 206,480 | 774,897 | 167,920 | -191,001 | -71,483 | 45,989 | -40,572 | -75,765 | 332,832 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -509,299 | 509,299 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | 231,545 | 128,025 | -6,293 | 107,285 | 143,651 | 134,792 | 74,159 | 313 | 28 | 23 | 674 | 626 | 348 | 299 | 406 |
cash flow from financing | 1,187,893 | -197,947 | -2,228,274 | 4,194,534 | -80,226 | 716,793 | 280,639 | 775,210 | 167,948 | -190,978 | -580,108 | 555,914 | -40,224 | -75,466 | 276,673 |
cash and cash equivalents | |||||||||||||||
cash | 3,930,724 | 664,124 | -1,814,305 | 2,187,061 | 595,614 | 428,020 | -1,829,630 | 1,359,637 | 960,806 | 134,520 | -480,313 | 351,812 | -106,549 | -263,289 | 663,564 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 3,930,724 | 664,124 | -1,814,305 | 2,187,061 | 595,614 | 428,020 | -1,829,630 | 1,359,637 | 960,806 | 134,520 | -480,313 | 351,812 | -106,549 | -263,289 | 663,564 |
verathon medical (uk) ltd Credit Report and Business Information
Verathon Medical (uk) Ltd Competitor Analysis
Perform a competitor analysis for verathon medical (uk) ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in B 3 area or any other competitors across 12 key performance metrics.
verathon medical (uk) ltd Ownership
VERATHON MEDICAL (UK) LTD group structure
Verathon Medical (Uk) Ltd has no subsidiary companies.
Ultimate parent company
ROPER INDUSTRIES INC
#0010510
VERATHON MEDICAL INC
#0068776
2 parents
VERATHON MEDICAL (UK) LTD
03867024
verathon medical (uk) ltd directors
Verathon Medical (Uk) Ltd currently has 3 directors. The longest serving directors include Mr John Stipancich (Oct 2016) and Mr Jason Conley (Apr 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr John Stipancich | United States | 56 years | Oct 2016 | - | Director |
Mr Jason Conley | United States | 49 years | Apr 2017 | - | Director |
Mr Brandon Cross | United States | 39 years | Feb 2023 | - | Director |
P&L
December 2023turnover
15m
+41%
operating profit
1.3m
-7%
gross margin
32.4%
-7.51%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
5.9m
+0.38%
total assets
14.5m
+0.33%
cash
6.8m
+1.38%
net assets
Total assets minus all liabilities
verathon medical (uk) ltd company details
company number
03867024
Type
Private limited with Share Capital
industry
46180 - Agents specialised in the sale of other particular products
incorporation date
October 1999
age
26
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
diagnostic ultrasound (uk) ltd. (October 2006)
dxu limited (December 2003)
See moreaccountant
-
auditor
RICHARDSONS
address
rutland house 148 edmund street, birmingham, B3 2JR
Bank
-
Legal Advisor
-
verathon medical (uk) ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to verathon medical (uk) ltd. Currently there are 0 open charges and 1 have been satisfied in the past.
verathon medical (uk) ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for VERATHON MEDICAL (UK) LTD. This can take several minutes, an email will notify you when this has completed.
verathon medical (uk) ltd Companies House Filings - See Documents
date | description | view/download |
---|